Search Results - "Doerfler, Alexandria M."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing by Li, Ang, Lee, Ciaran M, Hurley, Ayrea E, Jarrett, Kelsey E, De Giorgi, Marco, Lu, Weiqi, Balderrama, Karol S, Doerfler, Alexandria M, Deshmukh, Harshavardhan, Ray, Anirban, Bao, Gang, Lagor, William R

    “…Adeno-associated viral (AAV) vectors packaging the CRISPR-Cas9 system (AAV-CRISPR) can efficiently modify disease-relevant genes in somatic tissues with high…”
    Get full text
    Journal Article
  2. 2

    Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase by De Giorgi, Marco, Jarrett, Kelsey E., Burton, Jason C., Doerfler, Alexandria M., Hurley, Ayrea, Li, Ang, Hsu, Rachel H., Furgurson, Mia, Patel, Kalyani R., Han, Jun, Borchers, Christoph H., Lagor, William R.

    Published in Journal of lipid research (01-12-2020)
    “…HMG-CoA reductase (Hmgcr) is the rate-limiting enzyme in the mevalonate pathway and is inhibited by statins. In addition to cholesterol, Hmgcr activity is also…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Targeting the Apoa1 locus for liver-directed gene therapy by De Giorgi, Marco, Li, Ang, Hurley, Ayrea, Barzi, Mercedes, Doerfler, Alexandria M., Cherayil, Nikitha A., Smith, Harrison E., Brown, Jonathan D., Lin, Charles Y., Bissig, Karl-Dimiter, Bao, Gang, Lagor, William R.

    “…Clinical application of somatic genome editing requires therapeutics that are generalizable to a broad range of patients. Targeted insertion of promoterless…”
    Get full text
    Journal Article
  5. 5

    AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9 by Li, Ang, Tanner, Mark R., Lee, Ciaran M., Hurley, Ayrea E., De Giorgi, Marco, Jarrett, Kelsey E., Davis, Timothy H., Doerfler, Alexandria M., Bao, Gang, Beeton, Christine, Lagor, William R.

    Published in Molecular therapy (03-06-2020)
    “…Adeno-associated viral (AAV) vectors are a leading candidate for the delivery of CRISPR-Cas9 for therapeutic genome editing in vivo. However, AAV-based…”
    Get full text
    Journal Article
  6. 6

    Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research by Jarrett, Kelsey E, Lee, Ciaran, De Giorgi, Marco, Hurley, Ayrea, Gillard, Baiba K, Doerfler, Alexandria M, Li, Ang, Pownall, Henry J, Bao, Gang, Lagor, William R

    “…OBJECTIVE—Atherosclerosis studies in Ldlr knockout mice require breeding to homozygosity and congenic status on C57BL6/J background, a process that is both…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Recent advances in genome editing for cardiovascular disease by Doerfler, Alexandria M., Walkey, Christopher J., Lagor, William R.

    Published in Current opinion in cardiology (01-05-2020)
    “…PURPOSE OF REVIEWThis review highlights recent progress in applying genome editing to the study and treatment of cardiovascular disease (CVD). RECENT…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Abstract 425: Genetic Inhibition Of Hepatic Dolichol Biosynthesis Results In Hypolipidemia by De Giorgi, Marco, Doerfler, Alexandria M, Hurley, Ayrea, Walkey, Christopher, Lagor, William R

    “…Dolichol is a nonsterol isoprenoid derived from the mevalonate pathway. Dehydrodolichyl diphosphate synthase subunit (DHDDS) is a branch point enzyme that - in…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Abstract 216: Modeling Statin Hepatotoxicity with Acute Liver Specific Deletion of HmgCoA Reductase by De Giorgi, Marco, Jarrett, Kelsey E, Burton, Jason C, Doerfler, Alexandria M, Hurley, Ayrea, Hsu, Rachel H, Lagor, William R

    “…Abstract only Hmg-CoA Reductase (Hmgcr) catalyzes the conversion of Hmg-CoA to mevalonate, which is the rate-limiting step in the cholesterol biosynthetic…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Abstract 032: Somatic Editing of Ldlr with AAV-CRISPR for Atherosclerosis Studies by Jarrett, Kelsey E, Doerfler, Alexandria M, Hurley, Ayrea, Hsu, Rachel H, De Giorgi, Marco, Li, Ang, Pownall, Henry J, Lee, Ciaran, Bao, Gang, Lagor, William R

    “…Abstract only Background: Current methods to study genetic contributions to atherosclerosis are time-consuming and expensive. The Ldlr and Apoe knockout (KO)…”
    Get full text
    Journal Article
  16. 16

    Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase by De Giorgi, Marco, Jarrett, Kelsey E, Burton, Jason C, Doerfler, Alexandria M, Hurley, Ayrea, Li, Ang, Hsu, Rachel H, Furgurson, Mia, Patel, Kalyani R, Han, Jun, Borchers, Christoph H, Lagor, William R

    Published in Journal of lipid research (01-12-2020)
    “…HMG-CoA reductase (Hmgcr) is the rate-limiting enzyme in the mevalonate pathway and is inhibited by statins. In addition to cholesterol, Hmgcr activity is also…”
    Get full text
    Journal Article
  17. 17

    Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase by De Giorgi, Marco, Jarrett, Kelsey E, Burton, Jason C, Doerfler, Alexandria M, Hurley, Ayrea, Li, Ang, Hsu, Rachel H, Furgurson, Mia, Patel, Kalyani R, Han, Jun, Borchers, Christoph H, Lagor, William R

    Published in Journal of lipid research (01-12-2020)
    “…HMG-CoA reductase (Hmgcr) is the rate-limiting enzyme in the mevalonate pathway and is inhibited by statins. In addition to cholesterol, Hmgcr activity is also…”
    Get full text
    Journal Article